MedPath

High-intensity Interval Training Training Protocols on Cardiorespiratory Parameters in Patients With Type 2 Diabetes

Not Applicable
Completed
Conditions
Diabetes
Interventions
Other: Long duration
Other: Short duration
Registration Number
NCT03487029
Lead Sponsor
Hacettepe University
Brief Summary

Aim: To assess whether there are different training effects on glucose concentration and cardiorespiratory parameters of different high-intensity training protocols in patients with type 2 diabetes.

Type 2 diabetes is a highly prevalent disease associated with cardiovascular disease leading to high levels of mortality, morbidity and health expenditure, characterized by impaired glucose control during activities and reduced aerobic exercise capacity .

Exercise training is the most effective way to improve compliance, reduce blood glucose concentration and increase insulin sensitivity. Training increases muscle capacity, oxidative capacity and glucose transport, peripheral insulin sensitivity is improved.

Exercise training with high-intensity interval (resting and exercise period) High Intensity Interval Training (HIIT) is a form of exercise training that has recently been widely used in the management of type 2 diabetes, including short duration high intensity exercise periods and lower severity or passive rest periods. There are different HIIT exercise training programs according to physiological responses in the literature. However, long-term and short-term HIIT training training programs were not compared in terms of their effect on glucose concentration and cardiorespiratory fitness. The aim of this study was to compare the effects of different HIIT exercise training programs so that exercise programs for patients with type 2 diabetes could be planned more effectively.

Detailed Description

This study will be participated patients with Type 2 diabetes. Patients' laboratory values, pulmonary function test, respiratory muscle strength, exercise capacity, physical activity level, quality of life will be evaluated.

Pulmonary function test will be assesed with spirometer, respiratory muscle strength will be evaluated with mouth pressure. Exercise capacity will be evaluated using six minute walking test, incremental shuttle walk test, cycle ergometer. Muscle oxigeneration will be asssed with wearable lactate threshold predicting device. Physical activity level will be evaluated trial accelerometer.

Then, patients will be randomly divided two high intensity interval exercise training groups.

First group: short duration high intensity exercise training (Exercise load phase : 30sn %100 Patients performance, rest phase: 120sn %25 patients performance) Second group: Long duration high intensity interval exercise training (Exercise load phase : 4 dk %100 Patients performance, rest phase: 120sn %25 patients performance) All patients will participate three times a week during eight weeks. The muscle oxigeneration, blood glucose consantration, blood pressure, heart rate will be recorded before and after each exercise session. After 8 week, all test will be done again.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • diagnosis of type 2 diabetes
  • aged 18-64 years
  • patients can walk and cooperative
  • body mass index is less than 40 kg / m2
Exclusion Criteria

Individuals have known lung disease,have undergone any cardiac event or surgery within the past six months, have uncontrolled hypertension, and have diabetic complications such as nephropathy, retinopathy and severe neuropathy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
long duration groupLong duration4dk %85 Wmax 120sn %25 Wmax 3 sessions/week total 8 weeks
short duration groupShort duration30sn %100 Wmax 120sn %25 Wmax 3 sessions/week total 8 weeks
Primary Outcome Measures
NameTimeMethod
muscle oxigenerationChange from baseline muscle oxigeneration at 8 weeks

It is evaluate with wearable lactate threshold device on gastrocinemius

Secondary Outcome Measures
NameTimeMethod
pulmonary parameter-Forced vital capacitybefore and after 8 weeks

Forced vital capacity will be evaluated

pulmonary parameter-Forced vital capacity in the first secondbefore and after 8 weeks

Forced vital capacity in the first second will be evaluated

The blood glucose consentrationbefore and after 8 weeks

It is evaluate with sample from blood

Functional Exercise capacitybefore and after 8 weeks

İt is evaluated with six minute walk test

Maximal exercise capacitybefore and after 8 weeks

İt is evaluated using with incremental shuttle test

Symptom limited maximal exercise capacitybefore and after 8 weeks

İt is evaluated with cycle ergometer test

Physical activity levelbefore and after 8 weeks

ıt is assessed using accelerometer

Lipit profile-High density lipoprotein cholesterolbefore and after 8 weeks

High density lipoprotein cholesterol wiil be assesed

Lipit profile- low density lipoprotein cholesterolbefore and after 8 weeks

low density lipoprotein cholesterol wiil be assesed

Lipit profile- trigliseridebefore and after 8 weeks

trigliseride wiil be assesed

pulmonary parameter-Mid expiratory flow ratebefore and after 8 weeks

Mid expiratory flow rate will be evaluated

Respiratory muscle strengthbefore and after 8 weeks

It is evaluated with mouth pressure

pulmonary parameter-Peak expiratory flowbefore and after 8 weeks

Peak expiratory flow will be evaluated

Trial Locations

Locations (1)

Hacettepe University

🇹🇷

Ankara, State, Turkey

© Copyright 2025. All Rights Reserved by MedPath